Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03791398
Title BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (379)
Acronym 379
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Khaldoun Almhanna
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals Providence Rhode Island 02903 United States Details
*Shaded cells indicate that there was no data available from for the field